Reduction of cisplatin toxicity in cultured renal tubular cells by the bioflavonoid quercetin

Archives of Toxicology

Volumn 72, Issue 8, 1998, Pages 536-540

  Kuhlmann, Martin K ^a   Horsch, Ernst ^a   Burkhardt, Gunther ^a   Wagner, Martina ^a   Köhler, Hans ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Cisplatin; Cytoprotection; Flavonoid; Nephrotoxiciy; Quercetin

Indexed keywords

BIOFLAVONOID; CATECHIN; CISPLATIN; LACTATE DEHYDROGENASE; QUERCETIN; RUTOSIDE; SILIBININ;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL LINE; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DOSE TIME EFFECT RELATION; IN VITRO STUDY; KIDNEY TUBULE CELL; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; CISPLATIN; FLAVONOIDS; KIDNEY TUBULES; L-LACTATE DEHYDROGENASE; LLC-PK1 CELLS; QUERCETIN; SWINE; TETRAZOLIUM SALTS; THIAZOLES;

ANIMALIA;

EID: 0031853429     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002040050539     Document Type: Article

References (30)

1. 1 cells. Biochem Pharmacol 44: 382-387
2. Bull JM, Strebel FR, Sunderland BA, Bulger RE, Edwards M, Siddik ZH, Newman RA (1988) O-(β-Hydroxyethyl)-rutoside mediated protection of renal injury associated with cis-diamminedichloroplatinum(II)/hyperthermia treatment. Cancer Res 48: 2239-2244
3. Cross HJ, Tilby M, Chipman JK, Ferry DR, Gescher A (1996) Effect of quercetin on the genotoxic potential of cisplatin. Int J Cancer 66: 404-408
4. Dobyan DC, Bull JM, Strebel FR, Sunderland BA, Bulger RE (1986) Protective effects of (o-[β-hydroxyethyl]-rutoside) on cisplatinum induced acute renal failure in rats. Lab Invest 55: 557-563
5. Dunnick JK, Hailey JR (1992) Toxicity and carcinogenicity studies of quercetin, a natural component of foods. Fundam Appl Toxicol 19: 423-431
6. Gaedecke J, Fels LM, Bokemeyer C, Mengs U, Stolte H, Lentzen H (1996) Cisplatin nephrotoxicity and protection by silibinin. Nephrol Dial Transplant 11: 55-62
7. 1 and MDCK). Am J Physiol 248: F536-544
8. Hertog MGL, Fesgens EJM, Hollmann PCH, Katan MB, Kromhout D (1993) Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 342: 1007-1011
9. Hertog MGL, Fesgens EJM, Hollmann PCH, Katan MB, Kromhout D (1994) Dietary antioxidant flavonoids and cancer risk in The Zutphen Elderly Study. Nutr Cancer 22: 175-184
10. Hertog MGL, Kromhout D, Aravanis C, Blackburn H, Buzina R, Fidanza F, Giampaoli S, Jansen A, Menotti A, Nedeljkovc S, Pekkarinen M, Simic BS, Toshima H, Feskens EJM, Hollmann PCH, Katan MB (1995) Flavonoid intake and long term risk of coronary heart disease and cancer in the Seven Countries Study. Arch Intern Med 155: 381-386
11. Hertog MGL, Bueno-de-Mesquita HB, Fehily AM, Sweetnam PM, Elwood PC, Kromhout D (1996) Fruit and vegetable consumption and cancer mortality in the Caerphilly Study. Cancer Epidemiol Biomarkers Prev 5: 673-677
12. Holmann J, Doppler W, Jakob A, Maly K, Posch L, Überall F, Grünicke HH (1988) Enhancement of the antiproliferative effect of cis-diamminedichloroplatinum(II) and nitrogen mustard by inhibitors of protein kinase C. Int J Cancer 42: 382-388
13. Hofmann J, Fiebig HH, Winterhalter BR, Berger DP, Grünicke HH (1990) Enhancement of the antiproliferative activity of cis-diamminedichloroplatinum(II) by quercetin. Int J Cancer 45: 536-539
14. Husain SR, Cillard J, Cillard P (1987) Hydroxyl radical scavenging activity of flavonoids. Phytochemistry 26: 2489-2491
15. Korkina LG, Afanas'ev IB (1997) Antioxidant and chelating properties of flavonoids. Adv Pharmacol 38: 151-163
16. Kuhlmann MK, Burkhardt G, Köhler H (1997) Insights into potential cellular mechanisms of cisplatin nephrotoxicity and their clinical application. Nephrol Dial Transplant 12: 2478-2480
17. Leibbrandt MEI, Grushenka HIW, Metz AL, Oziba AA, Haskins JR (1995) Critical subcellular targets of cisplatin and related platinum analogs in rat proximal tubule cells. Kidney Int 48: 761-770
18. Liu B, Anderson D, Ferry DR, Seymour LW, DeTakats PG, Kerr DJ (1995) Determination of quercetin in human plasma using reversed-phase high-performance liquid chromatography. J Chromatogr 666: 149-155
19. Meyer KB, Madias NE (1994) Cisplatin nephrotoxicity. Miner Electrolyte Metab 20: 201-213
20. 1 cells as a model for cis-diamminedichloroplatinum(II) nephrotoxicity and modulation by thiol rescue agents. Cancer Res 48: 6017-6024
21. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J Immunol Methods 65: 55-63
22. Nakayama T, Yamada M, Osawa T, Kawakishi S (1993) Suppression of active oxygen-induced cytotoxicity by flavonoids. Biochem Pharmacol 45: 265-267
23. Oosterhuis JW, Nikicicz E, Meiring A (1987) Diethyldithiocarbamate (DDTC) rescue interferes with antitumor activity of cisplatin in treatment of murine teratocarcinoma. Proc Am Assoc Cancer Res 28: 313-318
24. Robak J, Gryglewski RJ (1988) Flavonoids are scavengers of superoxide anions. Biochem Pharmacol 37: 837-841
25. +)-dependent ATPase. Biochim Biophys Acta 772: 295-306
26. Safirstein R, Miller P, Gutenplan JB (1984) Uptake and metabolism of cisplatin by rat kidney. Kidney Int 25: 753-758
27. Saija A, Scalese M, Lanza M, Marzullo D, Bonina F, Castelli F (1995) Flavonoids as antioxidant agents: importance of their interaction with biomembranes. Free Radic Biol Med 19: 481-486
28. Scambia G, Ranalletti FO, Benedetti-Panici P, Piantelli M, Bonanno G, DeVincenzo R, Ferrandina G, Maggiano H, Capelli A, Mancuso S (1992) Inhibitory effect of quercetin on primary ovarian and endometrial cancer and synergistic activity with cis-diamminedichloroplatinum(II). Gynecol Oncol 45: 13-19
29. 1 cells. J Biol Chem 261: 3325-3332
30. Terao J, Piskula M, Yao Q (1994) Protective effect of epicatechin, epicatechin gallate, and quercetin on lipid peroxidation in phospholipid bilayers. Arch Biochem Biophys 308: 278-284